HomeIndustriesHomebuilding & Real EstateKROS, ASND, GOSS: Biopharma Stocks To Watch In 2024

KROS, ASND, GOSS: Biopharma Stocks To Watch In 2024

Keros Therapeutics (KROS) is a clinical-stage biopharmaceutical company that develops therapies for hematologic and cardiovascular disease. Wedbush’s Andreas Argyrides breaks down the biopharma space, as Wedbush has an outperform rating and an $86 price target on KROS. He also talks about Asecndis Pharma (ASND) which is on Wedbush’s top picks for 2024. He then goes over Gossamer Bio (GOSS) which is developing Seralutinib (GB002) for the treatment of PAH. Tune in to find out more about the stock market today.

Market On Close

21 Dec 2023

SHARE

ON AIR
1:30 am
Gamma On
replay
12:00 am
Gamma On
REPLAY
12:30 am
Gamma On
REPLAY
1:00 am
Gamma On
REPLAY
ON AIR
1:30 am
Gamma On
REPLAY
2:30 am
Gamma On
REPLAY
3:00 am
Gamma On
REPLAY
3:30 am
Gamma On
REPLAY
4:00 am
Gamma On
REPLAY
5:00 am
Gamma On
REPLAY
6:00 am
Gamma On
REPLAY
education
7:00 am
Inside the Mind of a Trader
REPLAY
education
7:30 am
Inside the Mind of a Trader
REPLAY
education
8:00 am
Inside the Mind of a Trader
REPLAY
8:30 am
Market Overtime
REPLAY
education
9:00 am
Your First Trade
REPLAY
education
9:30 am
Your First Trade
REPLAY
education
10:00 am
Your First Trade
REPLAY
education
10:30 am
Your First Trade
REPLAY
education
11:00 am
Your First Trade
REPLAY
11:30 am
Market Overtime
REPLAY
12:00 pm
Gamma On
REPLAY
12:30 pm
Gamma On
REPLAY
1:00 pm
Gamma On
REPLAY
1:30 pm
Gamma On
REPLAY
2:30 pm
Gamma On
REPLAY
3:00 pm
Gamma On
REPLAY
3:30 pm
Gamma On
REPLAY
4:00 pm
Gamma On
REPLAY
5:00 pm
Gamma On
REPLAY
6:00 pm
Gamma On
REPLAY
7:00 pm
Market Overtime
REPLAY
7:30 pm
Market Overtime
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market Overtime
REPLAY
9:00 pm
Trading 360
REPLAY
10:00 pm
Fast Market
REPLAY
11:00 pm
Next Gen Investing
REPLAY

Schwab Network's Newsletters

Daily insights for every investor